As a proud sponsoring partner of the 10th Neurodegenerative Drug Development Summit (NDD) in Boston, Lipotype is attending this event from 28th to 30th March.
We are looking forward to discussing how lipidomics can support and add value to drug development research for neurodegenerative diseases.
In addition, for those who would like to talk to us about Lipidomics, our Account Manager Caroline Dressler, CTO Christian Klose, and COO Oliver Uecke will be in Boston until this Thursday (31.03.2022).
To arrange a meeting, please send an email to Ms. Dressler at firstname.lastname@example.org
For more information about NDD Boston, please refer to the link below.